週边神经损伤市场规模、份额和增长分析：按损伤类型、按产品、按治疗、按手术、按应用、按地区 - 行业预测，2024-2031 年

2022年周边神经损伤市场规模预计为14.3亿美元，预测期内（2024-2031年）复合年增长率为7.65%，从2023年的15.4亿美元增至2031年的27.8亿美元。 10,000,000 美元。

近年来，由于创伤相关事故的增加、神经修復技术的进步以及人口老化等因素，週边神经损伤市场取得了显着的进展。手术方法和生物材料的改进显着改善了患者的预后，并推动了市场的扩张。神经刺激和神经调节疗法也使治疗选择多样化。学术界、医疗公司和研究机构之间的合作正在推动创新疗法的发展。然而，治疗费用高、报销有限等挑战仍然存在。随着对有效解决方案的需求增加，市场相关人员必须克服这些障碍，使该行业成为医疗保健领域充满活力的行业。

目录

介绍

• 这项研究的目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 价值链分析
• 价格分析
• Start-Ups分析
• 监管环境
• 专利分析
• 管道分析
• 成功的关键因素
• 市场吸引力指数
• 竞争程度
• 主要投资机会
• 生态系绘图

週边神经损伤市场：按损伤类型

• 市场概况
• 创伤
• 压力损伤
• 手术损伤

週边神经损伤市场：副产品

• 市场概况
• 神经导管
• 神经保护器
• 神经连接器
• 神经包扎

週边神经损伤市场：依治疗分类

• 市场概况
• 手术治疗
• 物理治疗
• 药物治疗

週边神经损伤市场：透过手术

• 市场概况
• 直接神经修復
• 神经移植
• 干细胞疗法

週边神经损伤市场：依应用分类

• 市场概况
• 下肢
• 上肢

週边神经损伤市场：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Medtronic plc（Ireland）
• Boston Scientific Corporation（United States）
• Abbott Laboratories（United States）
• Stryker Corporation（United States）
• Baxter International Inc.（United States）
• Integra LifeSciences Holdings Corporation（United States）
• Axogen Corporation（United States）
• NeuroPace, Inc.（United States）
• Nuvectra Corporation（United States）
• OrthoPediatrics Corp.（United States）
• Polyganics BV（Netherlands）
• Zimmer Biomet Holdings, Inc.（United States）
• Smith & Nephew plc（United Kingdom）
• NeuroMetrix, Inc.（United States）
• MicroPort Scientific Corporation（China）
• Nihon Kohden Corporation（Japan）
• Natus Medical Incorporated（United States）
• LivaNova plc（United Kingdom）
• AxoGen Corporation（United States）
• Bioventus LLC（United States）

Peripheral Nerve Injuries Market size was valued at USD 1.43 billion in 2022 and is poised to grow from USD 1.54 billion in 2023 to USD 2.78 billion by 2031, at a CAGR of 7.65% during the forecast period (2024-2031).

Recent years have witnessed significant advancements in the peripheral nerve injuries market, fueled by factors such as rising trauma-related incidents, advancements in nerve repair technologies, and an aging population. Improvements in surgical methods and biomaterials have notably enhanced patient outcomes, stimulating market expansion. Neurostimulation and neuromodulation therapies have also diversified treatment options. Collaborations among academia, medical firms, and research entities have spurred innovative therapy development. Nevertheless, challenges like high treatment costs and limited reimbursements persist. Market stakeholders must navigate these hurdles amidst growing demand for effective solutions, making this sector dynamic within healthcare.

Top-down and bottom-up approaches were used to estimate and validate the size of the Peripheral Nerve Injuries Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Peripheral Nerve Injuries Market Segmental Analysis

The peripheral nerve injuries market can be segmented based on injury type, product, treatment, surgery, application, and region. Based on injury type, the market is segmented into traumatic injuries, compression injuries, and surgical injuries. Based on product, the market is segmented into nerve conduit, nerve protector, nerve connector, and nerve wraps. Based on treatment, the market is segmented into surgical interventions, physical therapy, and pharmaceutical interventions. Based on surgery, the market is segmented into direct nerve repair, nerve grafting, and stem cell therapy. Based on application, the market is segmented into lower extremities and upper extremities. Geographically, the market is divided into North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.

Drivers of the Peripheral Nerve Injuries Market

Technological advancements, including the development of innovative wound care products and minimally invasive surgical techniques, significantly drive growth in the Peripheral Nerve Injuries Market. These innovations enhance the effectiveness and efficiency of burn treatments, resulting in improved patient outcomes and shorter recovery times.

Restraints in the Peripheral Nerve Injuries Market

The treatment expenses associated with peripheral nerve injuries, encompassing surgeries, rehabilitation, and ongoing care, can impose significant financial burdens. These high costs often restrict access to care for many patients and hinder market expansion. Furthermore, despite advancements in medical technology, treatment options for peripheral nerve injuries remain limited. Nerve regeneration is intricate, and achieving full recovery remains elusive, posing considerable challenges for both patients and healthcare providers alike.

Market Trends of the Peripheral Nerve Injuries Market

Technological advancements in nerve repair are a key trend in the peripheral nerve injuries market, marked by ongoing developments in nerve regeneration technologies. Researchers and medical device firms are innovating with nerve conduits, neurostimulation devices, and bioengineered materials to enhance treatment outcomes. These advancements aim to accelerate nerve regeneration, shorten recovery periods, and mitigate complications. Concurrently, there is an increasing incidence of peripheral nerve injuries, driven by factors like sports-related trauma, accidents, and an aging population, expanding the patient base in need of effective treatments. Additionally, personalized medicine is gaining traction, tailoring treatments based on injury type, severity, patient demographics, and health status, promising improved efficacy and minimized adverse effects.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Value Chain Analysis
• Pricing Analysis
• Start Up Analysis
• Regulatory Landscape
• Patent Analysis
• Pipeline Analysis
• Key Success Factors
• Market Attractiveness Index
• Degree of Competition
• Top Investment Pockets
• Ecosystem Mapping

Peripheral Nerve Injuries Market by Injury Type

• Market Overview
• Traumatic Injuries
• Compression Injuries
• Surgical Injuries

Peripheral Nerve Injuries Market by Product

• Market Overview
• Nerve Conduit
• Nerve Protector
• Nerve Connector
• Nerve Wraps

Peripheral Nerve Injuries Market by Treatment

• Market Overview
• Surgical Interventions
• Physical Therapy
• Pharmaceutical Interventions

Peripheral Nerve Injuries Market by Surgery

• Market Overview
• Direct Nerve Repair
• Nerve Grafting
• Stem Cell Therapy

Peripheral Nerve Injuries Market by Application

• Market Overview
• Lower Extremities
• Upper Extremities

Peripheral Nerve Injuries Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Axogen Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuvectra Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OrthoPediatrics Corp. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Polyganics BV (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroMetrix, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AxoGen Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioventus LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments